Tetragon Partners GP Ltd Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001515070

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q3 2026 · 34 positions · Total reported value $730.98M · Top-10 concentration 81.6% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.5% · 4 new · 5 cut · 6 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +7.8% · vs SPY +5.7% · Prev Value $613.69M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.0% · vs SPY +2.8% · Latest Value $730.98M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Tetragon Partners GP Ltd disclosed 34 equity positions with a combined reported value of $730.98M. The filing implies a focused portfolio: its ten largest positions account for 81.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were PATH ($417.30M), KGEI ($42.26M), PHVS ($26.59M). By sector, the heaviest allocations are Technology 62.3%, Health Care 28.3%. Versus the prior quarter, allocation shifted toward Technology (+1.5pp) and away from Health Care (-1.8pp).

Versus the prior quarter, Tetragon Partners GP Ltd opened 4 new positions, trimmed 5 and fully exited 6, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q3 2026 were NBIX ($6.67M), UBER ($4.89M), ANTX ($3.21M).

Of the 6 positions fully exited versus the prior quarter, the largest were ACAD ($4.25M), RARE ($3.34M), CUE ($2.96M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • NBIX NEUROCRINE BIOSCIENCES INC · $6.67M
  • UBER UBER TECHNOLOGIES INC · $4.89M
  • ANTX AN2 THERAPEUTICS INC · $3.21M
  • SLGL SOL-GEL TECHNOLOGIES LTD · $617.04K

Fully Exited (vs previous quarter)

  • ACAD ACADIA PHARMACEUTICALS INC · prev qtr: $4.25M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $3.34M
  • CUE CUE BIOPHARMA INC · prev qtr: $2.96M
  • KPTI KARYOPHARM THERAPEUTICS INC · prev qtr: $2.45M
  • ACRS ACLARIS THERAPEUTICS INC · prev qtr: $2.12M
  • AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $152.66K

Insider Transactions (Form 4)

Latest Tetragon Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Tetragon Partners GP Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 36 positions worth $613.69M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 36 positions · $613.69M reported value (Q2 2026)
  • Top 10 holdings = 76.6% of reported value
  • Largest position: PATH (UIPATH INC CL A) at 54.8%
  • Average position size: $17.05M

Sector Tilt

  • Information Technology 60.8%
  • Health Care 30.2%
  • Energy 5.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 16 added, 7 reduced, 4 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Aggressive growth tilt, particularly in biotech/healthcare, with significant new positions and share increases; modest reduction in Workiva suggests selective profit-taking. 2. Key moves: - Added: PHVS (+183.5% shares), IONS (+353.8%), ARWR (+102.4%), MBX (+8.4%), DFTX (+8.3%), PATH (+5.0%). - Reduced: WK (-10.0% shares). - Held: KGEI, AUTL, LYFT. 3. Portfolio structure: Highly active, concentrated (top-10 = 79.37%), overweight Technology/Health Care; high-risk appetite (small-cap biotech focus). 4. Per-holding one-liner: - PATH: UiPath (automation software). - KGEI: Kolibri Global Energy (oil/gas). - PHVS: Pharvaris (orphan drugs). - IONS: Ionis Pharmaceuticals (RNA therapeutics). - AUTL: Autolus Therapeutics (cancer CAR-T). - ARWR: Arrowhead Pharmaceuticals (gene therapy). - LYFT: Lyft (ride-sharing). - WK: Workiva (compliance software). - MBX: MBX Biosciences (cancer immunotherapy). - DFTX: Definium Therapeutics (cancer targets). 5. Style summary: Concentrated, high-conviction biotech/tech growth fund with aggressive new bets and selective trimming.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:54

Sector Allocation

Technology 62.3%
Health Care 28.3%
Energy 5.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 32.50M $417.30M 57.09%
57.09%
Add
2 6.83M $42.26M 5.78%
5.78%
Hold
3 838.25K $26.59M 3.64%
3.64%
Add
4 440.93K $19.69M 2.69%
2.69%
Add
5 9.50M $18.43M 2.52%
2.52%
Hold
6 264.04K $17.28M 2.36%
2.36%
Add
7 1.00M $15.01M 2.05%
2.05%
Hold
8 225.00K $14.98M 2.05%
2.05%
Reduce
9 220.65K $12.93M 1.77%
1.77%
Add
10 310.89K $11.83M 1.62%
1.62%
Add
11 2.20M $10.89M 1.49%
1.49%
Hold
12 295.94K $9.59M 1.31%
1.31%
Add
13 275.22K $9.30M 1.27%
1.27%
Add
14 226.68K $8.90M 1.22%
1.22%
Add
15 650.00K $8.90M 1.22%
1.22%
Add
16 206.78K $8.38M 1.15%
1.15%
Add
17 511.28K $8.24M 1.13%
1.13%
Add
18 447.24K $8.07M 1.10%
1.10%
Reduce
19 87.42K $6.95M 0.95%
0.95%
Add
20 47.01K $6.67M 0.91%
0.91%
New
21 19.67K $6.54M 0.90%
0.90%
Hold
22 35.00K $6.45M 0.88%
0.88%
Hold
23 200.00K $6.19M 0.85%
0.85%
Reduce
24 101.64K $6.15M 0.84%
0.84%
Add
25 500.00K $5.46M 0.75%
0.75%
Add
26 71.43K $4.89M 0.67%
0.67%
New
27 10.00K $3.40M 0.47%
0.47%
Hold
28 603.42K $3.21M 0.44%
0.44%
New
29 655.95K $2.77M 0.38%
0.38%
Reduce
30 50.00K $1.66M 0.23%
0.23%
Hold
31 56.05K $668.70K 0.09%
0.09%
Hold
32 26.80K $624.12K 0.09%
0.09%
Reduce
33 8.31K $617.04K 0.08%
0.08%
New
34 75.10K $141.94K 0.02%
0.02%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 23% of its Top-10 each quarter and backtests at F1 77% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 77% · recall 77% · F1 77% · avg rank error 2.5 · Top-10 turnover 23%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% PATH · AUTL · LYFT · CXM · TAK · KGEI · BALY · AYX · CYTK · TARS PATH · AUTL · CYTK · AG · CXM · KGEI · BALY · TARS · SSRM · LYFT
2024-Q2 100% 100% 100% PATH · AUTL · AG · CYTK · CXM · KGEI · BALY · TARS · SSRM · LYFT PATH · AG · AUTL · KGEI · CXM · CYTK · BALY · LYFT · TARS · SSRM
2024-Q3 80% 80% 80% PATH · AG · AUTL · KGEI · CXM · CYTK · BALY · LYFT · TARS · SSRM PATH · AG · AUTL · KGEI · TARS · SSRM · CXM · LYFT · OTLY · INFA
2024-Q4 100% 100% 100% PATH · AG · AUTL · KGEI · TARS · SSRM · CXM · LYFT · OTLY · INFA PATH · KGEI · AUTL · SSRM · CXM · INFA · OTLY · AG · LYFT · TARS
2025-Q1 80% 80% 80% PATH · KGEI · SSRM · AUTL · CXM · INFA · OTLY · AG · LYFT · TARS PATH · KGEI · LAR · CXM · AG · INFA · AUTL · LYFT · TARS · CYTK
2025-Q2 60% 60% 60% PATH · KGEI · LAR · CXM · INFA · AG · AUTL · LYFT · TARS · ANNX PATH · BABA · KGEI · AUTL · JD · CXM · LYFT · LAR · OTLY · TCOM
2025-Q3 70% 70% 70% PATH · BABA · KGEI · AUTL · JD · CXM · OTLY · LYFT · LAR · TCOM PATH · BABA · KGEI · LYFT · CABO · PRGS · OTLY · CXM · AUTL · WK
2025-Q4 60% 60% 60% PATH · BABA · KGEI · PRGS · LYFT · OTLY · CABO · CXM · AUTL · WK PATH · KGEI · LYFT · AUTL · CXM · WK · ANNX · PRAX · CLDX · ARWR
2026-Q1 80% 80% 80% PATH · KGEI · LYFT · AUTL · CXM · WK · ANNX · PRAX · ARWR · CLDX PATH · KGEI · WBD · WK · LYFT · CXM · AUTL · CLDX · ARWR · NKTR
2026-Q2 70% 70% 70% PATH · KGEI · WBD · WK · LYFT · CXM · AUTL · CLDX · ARWR · NKTR PATH · KGEI · AUTL · LYFT · DFTX · WK · CXM · MBX · ALKT · CLDX
2026-Q3 ★ 70% 70% 70% PATH · KGEI · AUTL · DFTX · LYFT · WK · RLAY · MBX · CXM · CLDX PATH · KGEI · PHVS · IONS · AUTL · ARWR · LYFT · WK · MBX · DFTX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings4 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return-0.94%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+12.78%vs benchmark
Barra annualised vol39.0%Model estimate
Realised vol35.5%Annualised in window
Weighted beta1.03Raw exposure
Factor / specific risk45% / 55%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.385.292.098.8105.710-0110-2311-13Tetragon Partners GP LtdQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-0.94%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+12.78%Portfolio − benchmark
Arithmetic return sum-0.16%Difference vs compounded is the cross term
Weighted raw beta1.03Weighted holding betas
Realised volatility (annualised)35.48%Daily returns in window
Barra model volatility (annualised)38.98%Factor + specific
Factor share of variance44.8%Barra factors
Specific share of variance55.2%Stock residuals
Reported value$22.6M13F long US equity

2. Return attribution

The -0.16% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -7.93% -4947.2%
Momentum & Growth 3 -4.72% -2941.8%
Volatility & Tail Risk 7 +7.32% 4565.7%
Industry 12 +6.65% 4145.0%
Specific 1 -1.48% -921.8%
Return attribution (style + industry, %)-8.0-4.0+0.0+4.0+8.0Non-linear Size+0.52Information Technology-0.54Historical Volatility+0.55Size+0.57Beta+0.83Mid Cap-1.68Consumer Discretionary+1.70Communication Services+2.57Health Care+2.91Residual Volatility+3.37Skewness-4.18Momentum-4.84Kurtosis+6.24Turnover-7.38
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +0.90 +6.97% +6.24% 3893.4%
Residual Volatility Style +1.27 +2.66% +3.37% 2100.2%
Health Care Industry +0.36 +8.12% +2.91% 1812.9%
Communication Services Industry +0.27 +9.38% +2.57% 1605.0%
Consumer Discretionary Industry +0.22 +7.85% +1.70% 1062.5%
Beta Style +0.17 +4.85% +0.83% 517.6%
Size Style -0.31 -1.83% +0.57% 356.5%
Historical Volatility Style -0.04 -12.86% +0.55% 343.2%
Non-linear Size Style +0.57 +0.91% +0.52% 327.3%
Leverage (Downside Vol) Style -0.25 -1.82% +0.46% 287.6%
Liquidity Style +1.40 +0.22% +0.30% 188.0%
Growth Style +0.06 +1.57% +0.10% 62.3%
Amihud Illiquidity Style +0.67 -0.40% -0.27% -168.7%
Information Technology Industry +0.15 -3.57% -0.54% -335.4%
Specific Specific — — -1.48% -921.8%
Mid Cap Style +0.99 -1.69% -1.68% -1049.8%
Skewness Style +0.99 -4.21% -4.18% -2606.3%
Momentum Style +1.45 -3.34% -4.84% -3018.6%
Turnover Style +1.55 -4.77% -7.38% -4600.4%

3. Risk attribution

Annualised volatility is 38.98%; factor risk explains 44.8% of variance and specific risk 55.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-59.6-29.8+0.0+29.8+59.6Non-linear Size-0.83Communication Services+1.33Kurtosis+1.85Mid Cap+2.05Beta+2.09Information Technology+2.16Consumer Discretionary+2.59Skewness+2.70Turnover+3.04Health Care+3.19Residual Volatility+7.40Momentum+8.31Liquidity+8.74Specific+55.17
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 55.2% +21.51% 21.5%
Liquidity Style +1.40 8.7% +3.41% 3.4%
Momentum Style +1.45 8.3% +3.24% 3.2%
Residual Volatility Style +1.27 7.4% +2.89% 2.9%
Health Care Industry +0.36 3.2% +1.24% 1.2%
Turnover Style +1.55 3.0% +1.18% 1.2%
Skewness Style +0.99 2.7% +1.05% 1.1%
Consumer Discretionary Industry +0.22 2.6% +1.01% 1.0%
Information Technology Industry +0.15 2.2% +0.84% 0.8%
Beta Style +0.17 2.1% +0.81% 0.8%
Mid Cap Style +0.99 2.0% +0.80% 0.8%
Kurtosis Style +0.90 1.9% +0.72% 0.7%
Communication Services Industry +0.27 1.3% +0.52% 0.5%
Size Style -0.31 0.5% +0.20% 0.2%
Growth Style +0.06 0.3% +0.10% 0.1%
Leverage (Downside Vol) Style -0.25 -0.8% -0.30% -0.3%
Non-linear Size Style +0.57 -0.8% -0.32% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.31 +2.10 -2.41
Non-linear Size +0.57 +1.68 -1.10
Mid Cap +0.99 +0.13 +0.87
Beta +0.17 +1.29 -1.12
Momentum +1.45 +0.72 +0.73
Short-term Reversal +0.03 -0.64 +0.67
Residual Volatility +1.27 -0.40 +1.67
Historical Volatility -0.04 +0.86 -0.90
Liquidity +1.40 +0.11 +1.28
Amihud Illiquidity +0.67 +1.16 -0.49
Turnover +1.55 +0.21 +1.34
Growth +0.06 +0.58 -0.52
Leverage (Downside Vol) -0.25 +0.14 -0.40
Skewness +0.99 +0.24 +0.75
Kurtosis +0.90 +0.21 +0.68
Max Drawdown -0.03 -0.08 +0.06

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0UtilitiesConsumer StaplesIndustrialsInformation TechnologyConsumer DiscretionaryCommunication ServicesHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 15.1% 73.6% -14.30% -19.18% +3.44% +3.59% -2.86% +11.97%
Communication Services 27.4% 2.6% +0.00% -15.54% -0.55% +0.41% +3.86% +0.41%
Health Care 35.8% 1.7% +0.22% +9.16% +7.66% -0.15% -3.05% -0.08%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Discretionary 21.7% 8.8% +1.72% +5.56% +2.43% -0.34% -0.49% -0.12%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Total +10.16% +2.45% -1.48% +11.13%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RLAY RELAY THERAPEUTICS INC Health Care 35.80% +0.22% +0.08% Reduce
WBD WARNER BROS DISCOVERY INC Communication Services 27.45% +0.00% +0.00% Reduce
UBER UBER TECHNOLOGIES INC Consumer Discretionary 21.70% +1.72% +0.37% New
SNOW SNOWFLAKE INC Information Technology 15.06% -14.30% -2.15% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 UBER Consumer Discretionary 21.70% +1.72% +0.37%
2 RLAY Health Care 35.80% +0.22% +0.08%
3 WBD Communication Services 27.45% +0.00% +0.00%
4 SNOW Information Technology 15.06% -14.30% -2.15%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned -0.94%, versus -13.72% for the QQQ synthetic benchmark — an excess of +12.78%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +6.24%, Residual Volatility +3.37%, Health Care +2.91%; the largest drags came from Turnover -7.38%, Momentum -4.84%, Skewness -4.18%. Specific (stock-level) return contributed -1.48%.
  3. Risk attribution: Barra model volatility is 38.98% annualised; factor risk explains 45% of variance and specific risk 55%. The largest factor risk sources are Liquidity 8.7%, Momentum 8.3%, Residual Volatility 7.4%.
  4. Style tilt: size -0.31, momentum +1.45, volatility -0.04, liquidity +1.40; the weighted raw beta is 1.03. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+34.1 pp), the largest underweight is Information Technology (-58.6 pp). Allocation contributed +10.16%, selection +2.45% and interaction -1.48%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Tetragon Partners GP Ltd buy in 2026-Q3?

In its 2026-Q3 13F filing, Tetragon Partners GP Ltd reported 34 equity positions worth $730.98M in aggregate; its largest disclosed positions were PATH ($417.30M), KGEI ($42.26M), PHVS ($26.59M).

How large is Tetragon Partners GP Ltd's portfolio?

Tetragon Partners GP Ltd reported $730.98M of long equity holdings across 34 positions as of 2026-Q3. Top-10 holdings account for 81.6% of reported value.

What is Tetragon Partners GP Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tetragon-partners-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →